The Swiss Novartis Int AG creates the largest in Europe the producer of generics

The Swiss pharmaceutical company Novartis Int AG is going to allocate the division on production Sandoz generics in the separate company. It Novartis Int AG declared today, on August 25. Thus, the largest in Europe the producer of generics. Last year sales Sandoz reached $10 billion Novartis Int AG reported that else last year began revision of a portfolio of the assets and decided to concentrate on the new preparations protected by patents. Recently company tries to reduce costs: it plans to save $1 billion by 2024 and is going to dismiss 8 thousand employees...